GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug.

The deal will not only transform Novartis, but GSK as well, with both companies clearly focusing ... will help its existing Elanco Animal Health group expand its presence in the field.

GSK (GSK) continued losses for a seventh straight session as the stock closed xx% lower, at $xx on Friday. The British ...

To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the drugmaker. | To hear GSK CEO ...

GlaxoSmithKline (GB:GSK) has released an update. GSK has announced promising new data for its RSV vaccine, Arexvy, which ...

GSK is leaving the biopharma trade group BIO, a spokesperson confirmed, the latest large pharma to back out of the group.

This solidified GSK as a "here-to-stay" company in the market ... and he held the position of Vice-Chairman for PhRMA Local Working Group in Jordan. Discover how AI is transforming the ...

The FTSE 100 group won the case ... could change into NDMA when exposed to heat. However, GSK, Pfizer and the other companies ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Kering, GSK and Holcim are adopting science-based targets aimed at protecting land and water globally.